![Frederick M. Miesowicz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frederick M. Miesowicz
Nessuna posizione attualmente
Profilo
Dr. Frederick M.
Miesowicz is Chief Operating Officer & VP-Manufacturing at Argos Therapeutics, Inc.
Dr. Miesowicz was previously employed as Vice President-US Operations by Gamida Cell Ltd., Senior Vice President & General Manager by Hybridon Specialty Products, Vice President & General Manager by Cellcor, Inc., a Principal by Terumo Medical Corp., and Vice President by Dupont de Nemours.
He received his undergraduate degree from Siena College and a doctorate degree from Harvard University.
Precedenti posizioni note di Frederick M. Miesowicz
| Società | Posizione | Fine |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Direttore operativo | 22/04/2016 |
| GAMIDA CELL LTD. | Corporate Officer/Principal | - |
Hybridon Specialty Products | Corporate Officer/Principal | 01/01/2000 |
Cellcor, Inc.
 Cellcor, Inc. Miscellaneous Commercial ServicesCommercial Services Development of cellular therapies | Corporate Officer/Principal | 01/01/1998 |
DuPont de Nemours (Luxembourg) SARL
 DuPont de Nemours (Luxembourg) SARL Chemicals: SpecialtyProcess Industries Manufactures synthetic resins, synthetic rubbers and industrial chemicals | Corporate Officer/Principal | - |
Formazione di Frederick M. Miesowicz
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
28
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Hybridon Specialty Products | |
Cellcor, Inc.
Cellcor, Inc. Miscellaneous Commercial ServicesCommercial Services Development of cellular therapies | Commercial Services |
Siena College
 Siena College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terumo Medical Corp.
 Terumo Medical Corp. Medical SpecialtiesHealth Technology Manufactures and distributes medical products | Health Technology |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
DuPont de Nemours (Luxembourg) SARL
DuPont de Nemours (Luxembourg) SARL Chemicals: SpecialtyProcess Industries Manufactures synthetic resins, synthetic rubbers and industrial chemicals | Process Industries |
